Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -267,265 | -178,813 | -122,071 | -59,770 | -220,030 |
| Depreciation Amortization | 5,691 | 4,420 | 3,267 | 1,639 | 5,899 |
| Accounts receivable | -1,251 | -9 | -5 | -13 | -1,561 |
| Other Working Capital | -15,767 | -13,836 | 1,143 | -9,407 | 31,985 |
| Other Operating Activity | 32,772 | 23,651 | 13,694 | 6,863 | 34,242 |
| Operating Cash Flow | $-245,820 | $-164,587 | $-103,972 | $-60,688 | $-149,465 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,327 | 112,101 | 100,712 | 21,000 | 23,938 |
| PPE Investments | -5,341 | -2,427 | -1,587 | -1,168 | -3,401 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -10,695 |
| Purchase Sale Intangibles | -1,525 | -1,093 | -768 | -410 | -1,432 |
| Other Investing Activity | -1,525 | -1,093 | -768 | -410 | -1,432 |
| Investing Cash Flow | $-90,193 | $108,581 | $98,357 | $19,422 | $8,410 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | N/A | N/A | 20,000 |
| Debt Repayment | -7,603 | -5,076 | -2,551 | -2,525 | -2,598 |
| Common Stock Issued | 385,732 | 375,918 | 39,681 | 1,488 | 130,805 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -399 |
| Financing Cash Flow | $378,129 | $370,842 | $37,130 | $-1,037 | $147,808 |
| Beginning Cash Position | 80,440 | 80,440 | 80,439 | 80,439 | 73,687 |
| End Cash Position | 122,556 | 395,276 | 111,954 | 38,136 | 80,440 |
| Net Cash Flow | $42,116 | $314,836 | $31,515 | $-42,303 | $6,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | -245,820 | -164,587 | -103,972 | -60,688 | -149,465 |
| Capital Expenditure | -5,341 | -2,427 | -1,587 | -1,168 | -3,401 |
| Free Cash Flow | -251,161 | -167,014 | -105,559 | -61,856 | -152,866 |